TMUB1 and malignant colon neoplasm: Low-level methylation helps detect early precancerous lesions (Witte, Plass & Gerhauser, 2014), thereby indicating that TMUB1 has the potential to be used as a biomarker for the early diagnosis and treatment of colon cancer.